| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.048 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |